REGN 240906 1175.00P (REGN240906P1175000) Stock Options, News & Quotes

US OptionsDetailed Quotes

REGN240906P1175000

Watchlist

12.66
+6.27+98.12%

15min DelayClose Sep 3 16:00 ET

13.91High12.04Low

Intraday

5D
Daily

News

Koneksa Announces Regeneron Joins Data Syndication Program for Parkinson's Digital Biomarkers Study
BusinesswireSep 3 08:00 ET
Regeneron Pharmaceuticals(REGN.US) Officer Sells US$6.85 Million in Common Stock
Moomoo NewsAug 29 16:32 ET
J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab
Seeking AlphaAug 29 11:49 ET
Form 144 | Regeneron Pharmaceuticals(REGN.US) Officer Proposes to Sell 6.85 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 28, $Regeneron Pharmaceuticals(REGN.US)$ Officer Christopher Fenimore intends to sell 5,680 shares of its common stock on Aug 28, with a total market value of
Moomoo NewsAug 28 16:39 ET
Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish?
BarchartAug 28 09:30 ET
Regeneron's Bispecific Antibody Obtains EC Nod for Lymphoma
Zacks Aug 27 11:35 ET

Comments

Analysts Notebook

Aug 27 06:33

Columns Ready for Fed Rate Cuts? Biotech's Potential to Watch

The Federal Reserve appears poised to cut interest rates later this year. While the broader stock market might breathe a sigh of relief, certain sectors could be more significantly impacted than others. Biotechnology could be one of those sectors - at least, that's what Morgan Stanley believes.
In 2024, biotech stocks had a slow start, with the S&P Biotechnology Select Industry Index returning just under 4% in the first six months, compared to...

Fed rate cut ringing the bell: How to outsmart the trend?

Meltyy

Aug 27 01:16

FDA PDUFA Update:

🚀 Buckle up for upcoming PDUFAs in September! 👇
$Travere Therapeutic (TVTX.US)$ : FILSPARI (Sparsentan)
$Avadel Pharmaceuticals (AVDL.US)$ : LUMRYZ (FT218)
$Iterum Therapeutics (ITRM.US)$ : Sulopenem - AdCom 🗓️
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Dupixent
$Vanda Pharmaceuticals (VNDA.US)$ : Tradipitant
$Zevra Therapeutics (ZVRA.US)$ : Arimoclomol
$Heron Therapeutics (HRTX.US)$ : ZYNRELEF® Vial Access Needle
$Merck & Co (MRK.US)$ : KEYTRUDA+ chemotherapy
$Bristol-Myers Squibb (BMY.US)$ : KarXT (...

frankinglily

Aug 25 22:03

Argument:
The upcoming interest rate cuts are poised to benefit the biotech stock industry, setting the stage for strong performance in the coming quarters.
Reasons:
Cheaper Funding: Lower interest rates make it easier for biotech companies to access capital for research and development, accelerating their progress and growth potential.
Attractive Valuations: Biotech stocks are currently trading at attractive levels, offering investors an opportunity to capitalize on the sector's long-term pot...

Powell said it's time to cut: Will the market go wild?

In One Chart

Aug 22 07:58

Columns In One Chart | Wall Street Eyes New Sectors for the Next Stock Market Surge

Recent data shows that defensive sectors like utilities, consumer defensive, and healthcare have outperformed the information technology sector over the past month, reaching 52-week highs.
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...

Payrolls revised downward: Where are U.S. stocks headed?

273

111

Meltyy

Aug 21 02:00

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...